Hydromorphone
(XHILEZUETWRSHC-NRGUFEMZSA-N)
Structure
- SMILES
- O=C1CC[C@@H]2[C@@]34[C@H]1Oc1c4c(C[C@H]2N(CC3)C)ccc1O.Cl
- Molecular Formula:
- C17H20ClNO3
- Molecular Weight:
- 321.799
- Log P:
- 2.3702
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 2
- TPSA:
- 49.77
- CAS Number(s):
- 71-68-1
Synonym(s)
1.
Hydromorphone
2.
Dihydromorphinone
3.
Hydromorphon
4.
Dilaudid
5.
Hydromorphone Hydrochloride
6.
Laudacon
7.
Palladone
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 64 Canada Vigilance: 23 | Canada Vigilance US FAERS | |
| 2 | Drug abuse | FAERS: 46 Canada Vigilance: 86 | Canada Vigilance US FAERS | |
| 3 | Nausea | FAERS: 46 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 4 | Overdose | FAERS: 46 Canada Vigilance: 30 | Canada Vigilance US FAERS | |
| 5 | Medication Error | FAERS: 41 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 6 | Unresponsive to stimuli | FAERS: 41 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 7 | Incorrect dose administered | FAERS: 39 | US FAERS | |
| 8 | Pruritus | FAERS: 37 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 9 | Vomiting | FAERS: 36 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 10 | Drug Dependence | FAERS: 33 Canada Vigilance: 82 | Canada Vigilance US FAERS | |
| 11 | Pain | FAERS: 33 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 12 | Respiratory Depression | FAERS: 33 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 13 | Respiratory arrest | FAERS: 28 | US FAERS | |
| 14 | Somnolence | FAERS: 27 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 15 | Toxicity to various agents | FAERS: 27 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 16 | Drug withdrawal syndrome | FAERS: 25 Canada Vigilance: 17 | Canada Vigilance US FAERS | |
| 17 | Product quality issue | FAERS: 25 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 18 | Delirium | FAERS: 23 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 19 | Accidental overdose | FAERS: 19 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 20 | Depressed Level of Consciousness | FAERS: 16 Canada Vigilance: 11 | Canada Vigilance US FAERS | |
| 21 | Cardiac Arrest | FAERS: 15 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 22 | Completed Suicide | FAERS: 14 | US FAERS | |
| 23 | Headache | FAERS: 14 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 24 | Hypotension | FAERS: 14 | US FAERS | |
| 25 | Urticaria | FAERS: 14 | US FAERS | |
| 26 | Agitation | FAERS: 13 | US FAERS | |
| 27 | Respiratory distress | FAERS: 12 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 28 | Constipation | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 29 | Dizziness | FAERS: 11 | US FAERS | |
| 30 | Drug prescribing error | FAERS: 11 | US FAERS | |
| 31 | Hypersensitivity | FAERS: 11 | US FAERS | |
| 32 | Intentional drug misuse | FAERS: 11 | US FAERS | |
| 33 | Malaise | FAERS: 11 Canada Vigilance: 6 | Canada Vigilance US FAERS | |
| 34 | Drug administration error | FAERS: 10 | US FAERS | |
| 35 | Inadequate analgesia | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 36 | Lethargy | FAERS: 10 | US FAERS | |
| 37 | Respiratory Failure | FAERS: 10 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 38 | Accidental death | FAERS: 9 | US FAERS | |
| 39 | Anxiety | FAERS: 9 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 40 | Hypoxia | FAERS: 9 | US FAERS | |
| 41 | Pharmaceutical product complaint | FAERS: 9 | US FAERS | |
| 42 | Pulmonary congestion | FAERS: 9 | US FAERS | |
| 43 | Drug screen negative | FAERS: 8 | US FAERS | |
| 44 | Drug toxicity | FAERS: 8 | US FAERS | |
| 45 | Abdominal discomfort | FAERS: 7 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 46 | Angioedema | FAERS: 7 | US FAERS | |
| 47 | Asthenia | FAERS: 7 | US FAERS | |
| 48 | Chest Pain | FAERS: 7 | US FAERS | |
| 49 | Drug dispensing error | FAERS: 7 | US FAERS | |
| 50 | Euphoric mood | FAERS: 7 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 51 | Fatigue | FAERS: 7 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 52 | Feeling abnormal | FAERS: 7 | US FAERS | |
| 53 | Inappropriate schedule of drug administration | FAERS: 7 | US FAERS | |
| 54 | Incorrect route of drug administration | FAERS: 7 | US FAERS | |
| 55 | Mental status changes | FAERS: 7 | US FAERS | |
| 56 | Syncope | FAERS: 7 | US FAERS | |
| 57 | Weight decreased | FAERS: 7 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 58 | Bradycardia | FAERS: 6 | US FAERS | |
| 59 | Circumstance or information capable of leading to medication error | FAERS: 6 | US FAERS | |
| 60 | Drug diversion | FAERS: 6 Canada Vigilance: 9 | Canada Vigilance US FAERS | |
| 61 | Drug effect incomplete | FAERS: 6 | US FAERS | |
| 62 | Hypoventilation | FAERS: 6 | US FAERS | |
| 63 | Medication residue present | FAERS: 6 | US FAERS | |
| 64 | Pulmonary Embolism | FAERS: 6 | US FAERS | |
| 65 | Tremor | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 66 | Abdominal Pain | FAERS: 5 | US FAERS | |
| 67 | Accidental drug intake by child | FAERS: 5 | US FAERS | |
| 68 | Asthma | FAERS: 5 | US FAERS | |
| 69 | Cerebrovascular accident | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 70 | Chills | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 71 | Device computer issue | FAERS: 5 | US FAERS | |
| 72 | Erythema | FAERS: 5 | US FAERS | |
| 73 | Memory impairment | FAERS: 5 | US FAERS | |
| 74 | Myoclonus | FAERS: 5 | US FAERS | |
| 75 | Narcotic intoxication | FAERS: 5 | US FAERS | |
| 76 | Product label issue | FAERS: 5 | US FAERS | |
| 77 | Sepsis | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 78 | Swelling | FAERS: 5 | US FAERS | |
| 79 | Thrombosis | FAERS: 5 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 80 | Accidental exposure to product | FAERS: 4 | US FAERS | |
| 81 | Anaphylactic shock | FAERS: 4 | US FAERS | |
| 82 | Cardiovascular insufficiency | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 83 | Chest discomfort | FAERS: 4 | US FAERS | |
| 84 | Dehydration | FAERS: 4 | US FAERS | |
| 85 | Device Failure | FAERS: 4 | US FAERS | |
| 86 | Drug abuser | FAERS: 4 | US FAERS | |
| 87 | Foreign body embolism | FAERS: 4 | US FAERS | |
| 88 | Hypersplenism | FAERS: 4 | US FAERS | |
| 89 | Incorrect dose administered by device | FAERS: 4 | US FAERS | |
| 90 | Intentional product misuse | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 91 | Intestinal Obstruction | FAERS: 4 | US FAERS | |
| 92 | Laceration | FAERS: 4 | US FAERS | |
| 93 | Post procedural complication | FAERS: 4 | US FAERS | |
| 94 | Product measured potency issue | FAERS: 4 | US FAERS | |
| 95 | Product solubility abnormal | FAERS: 4 | US FAERS | |
| 96 | Product substitution issue | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 97 | Product use issue | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 98 | Restlessness | FAERS: 4 | US FAERS | |
| 99 | Shock | FAERS: 4 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 100 | Snoring | FAERS: 4 | US FAERS | |
| 101 | Suicide attempt | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 102 | Urinary Retention | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 103 | nervous system disorder | FAERS: 4 | US FAERS | |
| 104 | Accidental exposure to product by child | FAERS: 3 | US FAERS | |
| 105 | Alcohol poisoning | FAERS: 3 | US FAERS | |
| 106 | Apallic syndrome | FAERS: 3 | US FAERS | |
| 107 | Cancer Pain | FAERS: 3 | US FAERS | |
| 108 | Cyanosis | FAERS: 3 | US FAERS | |
| 109 | Drug Tolerance | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 110 | Foaming at mouth | FAERS: 3 | US FAERS | |
| 111 | Granuloma | FAERS: 3 | US FAERS | |
| 112 | Homicide | FAERS: 3 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 113 | Hydrocephalus | FAERS: 3 | US FAERS | |
| 114 | Hypophagia | FAERS: 3 | US FAERS | |
| 115 | Intentional device misuse | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 116 | Limb discomfort | FAERS: 3 | US FAERS | |
| 117 | Musculoskeletal discomfort | FAERS: 3 | US FAERS | |
| 118 | Myalgia | FAERS: 3 | US FAERS | |
| 119 | Myocardial Infarction | FAERS: 3 | US FAERS | |
| 120 | Neck Pain | FAERS: 3 | US FAERS | |
| 121 | Occupational exposure to product | FAERS: 3 | US FAERS | |
| 122 | Palpitations | FAERS: 3 | US FAERS | |
| 123 | Pneumonia | FAERS: 3 | US FAERS | |
| 124 | Poor quality drug administered | FAERS: 3 | US FAERS | |
| 125 | Postoperative ileus | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 126 | Product administration error | FAERS: 3 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 127 | Product container issue | FAERS: 3 | US FAERS | |
| 128 | Product tampering | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 129 | Screaming | FAERS: 3 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 130 | Sudden death | FAERS: 3 | US FAERS | |
| 131 | Tachycardia | FAERS: 3 | US FAERS | |
| 132 | Therapeutic response unexpected with drug substitution | FAERS: 3 | US FAERS | |
| 133 | Urinary Incontinence | FAERS: 3 | US FAERS | |
| 134 | Vital functions abnormal | FAERS: 3 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 135 | Acidosis | FAERS: 2 | US FAERS | |
| 136 | Activities of daily living impaired | FAERS: 2 | US FAERS | |
| 137 | Altered state of consciousness | FAERS: 2 | US FAERS | |
| 138 | Amnesia | FAERS: 2 | US FAERS | |
| 139 | Aphasia | FAERS: 2 | US FAERS | |
| 140 | Back Pain | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 141 | Bipolar Disorder | FAERS: 2 | US FAERS | |
| 142 | Blood gonadotrophin decreased | FAERS: 2 | US FAERS | |
| 143 | Brain Death | FAERS: 2 | US FAERS | |
| 144 | Breakthrough Pain | FAERS: 2 | US FAERS | |
| 145 | Catatonia | FAERS: 2 | US FAERS | |
| 146 | Cellulitis | FAERS: 2 | US FAERS | |
| 147 | Circumstance or information capable of leading to device use error | FAERS: 2 | US FAERS | |
| 148 | Cold sweat | FAERS: 2 | US FAERS | |
| 149 | Device malfunction | FAERS: 2 | US FAERS | |
| 150 | Disorientation | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 151 | Drug monitoring procedure not performed | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 152 | Dysuria | FAERS: 2 | US FAERS | |
| 153 | Epidermolysis | FAERS: 2 | US FAERS | |
| 154 | Excoriation | FAERS: 2 | US FAERS | |
| 155 | Exposure during breast feeding | FAERS: 2 | US FAERS | |
| 156 | Extra dose administered | FAERS: 2 | US FAERS | |
| 157 | Flushing | FAERS: 2 | US FAERS | |
| 158 | General physical health deterioration | FAERS: 2 | US FAERS | |
| 159 | Hypercapnia | FAERS: 2 | US FAERS | |
| 160 | Hyperreflexia | FAERS: 2 | US FAERS | |
| 161 | Incoherent | FAERS: 2 | US FAERS | |
| 162 | Infection | FAERS: 2 | US FAERS | |
| 163 | Infusion site mass | FAERS: 2 | US FAERS | |
| 164 | Loss of personal independence in daily activities | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 165 | Metabolic acidosis | FAERS: 2 | US FAERS | |
| 166 | Multiple Myeloma | FAERS: 2 | US FAERS | |
| 167 | Multiple drug overdose | FAERS: 2 | US FAERS | |
| 168 | Muscle Rigidity | FAERS: 2 | US FAERS | |
| 169 | Muscle tightness | FAERS: 2 | US FAERS | |
| 170 | Musculoskeletal Pain | FAERS: 2 | US FAERS | |
| 171 | PO2 decreased | FAERS: 2 | US FAERS | |
| 172 | Poisoning | FAERS: 2 | US FAERS | |
| 173 | Product label confusion | FAERS: 2 | US FAERS | |
| 174 | Product prescribing error | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 175 | Product residue present | FAERS: 2 | US FAERS | |
| 176 | Product taste abnormal | FAERS: 2 | US FAERS | |
| 177 | Pulmonary Hypertension | FAERS: 2 | US FAERS | |
| 178 | Retching | FAERS: 2 | US FAERS | |
| 179 | Rheumatoid Arthritis | FAERS: 2 | US FAERS | |
| 180 | Sopor | FAERS: 2 | US FAERS | |
| 181 | Unevaluable event | FAERS: 2 | US FAERS | |
| 182 | Vertigo | FAERS: 2 | US FAERS | |
| 183 | Wrong drug administered | FAERS: 2 | US FAERS | |
| 184 | Wrong technique in drug usage process | FAERS: 2 | US FAERS | |
| 185 | Abasia | FAERS: 1 | US FAERS | |
| 186 | Abdominal Compartment Syndrome | FAERS: 1 | US FAERS | |
| 187 | Akathisia | FAERS: 1 | US FAERS | |
| 188 | Anal sphincter atony | FAERS: 1 | US FAERS | |
| 189 | Anoxia | FAERS: 1 | US FAERS | |
| 190 | Application site mass | FAERS: 1 | US FAERS | |
| 191 | Arachnoiditis | FAERS: 1 | US FAERS | |
| 192 | Arterial thrombosis | FAERS: 1 | US FAERS | |
| 193 | Arteritis | FAERS: 1 | US FAERS | |
| 194 | Arthralgia | FAERS: 1 | US FAERS | |
| 195 | Ataxia | FAERS: 1 | US FAERS | |
| 196 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 197 | Azoospermia | FAERS: 1 | US FAERS | |
| 198 | Bedridden | FAERS: 1 | US FAERS | |
| 199 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 200 | Blood glucose increased | FAERS: 1 | US FAERS | |
| 201 | Bone pain | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 202 | Candidiasis | FAERS: 1 | US FAERS | |
| 203 | Carbon Monoxide Poisoning | FAERS: 1 | US FAERS | |
| 204 | Cardiac discomfort | FAERS: 1 | US FAERS | |
| 205 | Catheter related complication | FAERS: 1 | US FAERS | |
| 206 | Catheter related infection | FAERS: 1 | US FAERS | |
| 207 | Cerebellar infarction | FAERS: 1 | US FAERS | |
| 208 | Cheyne-Stokes Respiration | FAERS: 1 | US FAERS | |
| 209 | Clonus | FAERS: 1 | US FAERS | |
| 210 | Crying | FAERS: 1 | US FAERS | |
| 211 | Dementia | FAERS: 1 | US FAERS | |
| 212 | Dental caries | FAERS: 1 | US FAERS | |
| 213 | Dependence | FAERS: 1 | US FAERS | |
| 214 | Depression suicidal | FAERS: 1 | US FAERS | |
| 215 | Device leakage | FAERS: 1 | US FAERS | |
| 216 | Device occlusion | FAERS: 1 | US FAERS | |
| 217 | Diabetes Mellitus | FAERS: 1 | US FAERS | |
| 218 | Drug dose omission | FAERS: 1 | US FAERS | |
| 219 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 220 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 221 | Drug label confusion | FAERS: 1 | US FAERS | |
| 222 | Drug level decreased | FAERS: 1 | US FAERS | |
| 223 | Drug level increased | FAERS: 1 | US FAERS | |
| 224 | Drug screen positive | FAERS: 1 | US FAERS | |
| 225 | Dry skin | FAERS: 1 | US FAERS | |
| 226 | Dysarthria | FAERS: 1 | US FAERS | |
| 227 | Dyspepsia | FAERS: 1 | US FAERS | |
| 228 | Dysphonia | FAERS: 1 | US FAERS | |
| 229 | Embolism | FAERS: 1 | US FAERS | |
| 230 | Emotional disorder | FAERS: 1 | US FAERS | |
| 231 | Encephalitis | FAERS: 1 | US FAERS | |
| 232 | Endocarditis | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 233 | Epilepsy | FAERS: 1 | US FAERS | |
| 234 | Epistaxis | FAERS: 1 | US FAERS | |
| 235 | Eructation | FAERS: 1 | US FAERS | |
| 236 | Expired product administered | FAERS: 1 | US FAERS | |
| 237 | Face presentation | FAERS: 1 | US FAERS | |
| 238 | Feeling Cold | FAERS: 1 | US FAERS | |
| 239 | Foreign body trauma | FAERS: 1 | US FAERS | |
| 240 | Gait inability | FAERS: 1 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 241 | Hepatotoxicity | FAERS: 1 | US FAERS | |
| 242 | Hypogonadism | FAERS: 1 | US FAERS | |
| 243 | Hypokinesia | FAERS: 1 | US FAERS | |
| 244 | Hypomania | FAERS: 1 | US FAERS | |
| 245 | Ileus | FAERS: 1 | US FAERS | |
| 246 | Implantable defibrillator insertion | FAERS: 1 | US FAERS | |
| 247 | Inappropriate device programming | FAERS: 1 | US FAERS | |
| 248 | Incorrect drug administration duration | FAERS: 1 | US FAERS | |
| 249 | Incorrect drug administration rate | FAERS: 1 | US FAERS | |
| 250 | Increased bronchial secretion | FAERS: 1 | US FAERS | |
| 251 | Influenza | FAERS: 1 | US FAERS | |
| 252 | Infusion site erythema | FAERS: 1 | US FAERS | |
| 253 | Infusion site granuloma | FAERS: 1 | US FAERS | |
| 254 | Infusion site irritation | FAERS: 1 | US FAERS | |
| 255 | Injection site erythema | FAERS: 1 | US FAERS | |
| 256 | Injection site mass | FAERS: 1 | US FAERS | |
| 257 | Injection site necrosis | FAERS: 1 | US FAERS | |
| 258 | Injection site scab | FAERS: 1 | US FAERS | |
| 259 | Injection site ulcer | FAERS: 1 | US FAERS | |
| 260 | Injury associated with device | FAERS: 1 | US FAERS | |
| 261 | Intercepted product dispensing error | FAERS: 1 | US FAERS | |
| 262 | Laryngospasm | FAERS: 1 | US FAERS | |
| 263 | Lobar Pneumonia | FAERS: 1 | US FAERS | |
| 264 | Loss of bladder sensation | FAERS: 1 | US FAERS | |
| 265 | Malignant neoplasm progression | FAERS: 1 | US FAERS | |
| 266 | Mallory-Weiss Syndrome | FAERS: 1 | US FAERS | |
| 267 | Mediastinitis | FAERS: 1 | US FAERS | |
| 268 | Medication residue | FAERS: 1 | US FAERS | |
| 269 | Meningitis herpes | FAERS: 1 | US FAERS | |
| 270 | Metastatic Neoplasm | FAERS: 1 | US FAERS | |
| 271 | Middle insomnia | FAERS: 1 | US FAERS | |
| 272 | Multiple drug overdose accidental | FAERS: 1 | US FAERS | |
| 273 | Musculoskeletal stiffness | FAERS: 1 | US FAERS | |
| 274 | Nasopharyngitis | FAERS: 1 | US FAERS | |
| 275 | Necrosis | FAERS: 1 | US FAERS | |
| 276 | Needle issue | FAERS: 1 | US FAERS | |
| 277 | Nervousness | FAERS: 1 | US FAERS | |
| 278 | No adverse event | FAERS: 1 | US FAERS | |
| 279 | Obesity | FAERS: 1 | US FAERS | |
| 280 | Oropharyngeal blistering | FAERS: 1 | US FAERS | |
| 281 | Osteoporosis | FAERS: 1 | US FAERS | |
| 282 | Oxygen saturation abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 283 | Pain of skin | FAERS: 1 | US FAERS | |
| 284 | Pallor | FAERS: 1 | US FAERS | |
| 285 | Personality Change | FAERS: 1 | US FAERS | |
| 286 | Physical product label issue | FAERS: 1 | US FAERS | |
| 287 | Post-traumatic pain | FAERS: 1 | US FAERS | |
| 288 | Postoperative wound complication | FAERS: 1 | US FAERS | |
| 289 | Posturing | FAERS: 1 | US FAERS | |
| 290 | Presyncope | FAERS: 1 | US FAERS | |
| 291 | Product barcode issue | FAERS: 1 | US FAERS | |
| 292 | Product contamination physical | FAERS: 1 | US FAERS | |
| 293 | Product contamination with body fluid | FAERS: 1 | US FAERS | |
| 294 | Product dispensing error | FAERS: 1 | US FAERS | |
| 295 | Product dosage form issue | FAERS: 1 | US FAERS | |
| 296 | Product outer packaging issue | FAERS: 1 | US FAERS | |
| 297 | Product physical issue | FAERS: 1 | US FAERS | |
| 298 | Product size issue | FAERS: 1 | US FAERS | |
| 299 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 300 | Productive Cough | FAERS: 1 | US FAERS | |
| 301 | Pulmonary granuloma | FAERS: 1 | US FAERS | |
| 302 | Rectal Prolapse | FAERS: 1 | US FAERS | |
| 303 | Regurgitation | FAERS: 1 | US FAERS | |
| 304 | Respiratory tract infection fungal | FAERS: 1 | US FAERS | |
| 305 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 306 | Sedation complication | FAERS: 1 | US FAERS | |
| 307 | Starvation | FAERS: 1 | US FAERS | |
| 308 | Status Epilepticus | FAERS: 1 | US FAERS | |
| 309 | Stress | FAERS: 1 | US FAERS | |
| 310 | Substance Dependence | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 311 | Supraventricular tachycardia | FAERS: 1 | US FAERS | |
| 312 | Syringe issue | FAERS: 1 | US FAERS | |
| 313 | Tension Headache | FAERS: 1 | US FAERS | |
| 314 | Therapy cessation | FAERS: 1 | US FAERS | |
| 315 | Therapy regimen changed | FAERS: 1 | US FAERS | |
| 316 | Tinnitus | FAERS: 1 | US FAERS | |
| 317 | Tongue movement disturbance | FAERS: 1 | US FAERS | |
| 318 | Tooth Loss | FAERS: 1 | US FAERS | |
| 319 | Toxicologic test abnormal | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 320 | Traumatic Brain Injury | FAERS: 1 | US FAERS | |
| 321 | Urge Incontinence | FAERS: 1 | US FAERS | |
| 322 | Vasculitis | FAERS: 1 | US FAERS | |
| 323 | Venipuncture site swelling | FAERS: 1 | US FAERS | |
| 324 | Victim of chemical submission | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 325 | Wound contamination | FAERS: 1 | US FAERS | |
| 326 | Wrong technique in product usage process | FAERS: 1 | US FAERS | |
| 327 | Arthropathy | Canada Vigilance: 1 | Canada Vigilance | |
| 328 | Device infusion issue | Canada Vigilance: 1 | Canada Vigilance | |
| 329 | Impaired driving ability | Canada Vigilance: 1 | Canada Vigilance | |
| 330 | Incision site swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 331 | Incorrect route of product administration | Canada Vigilance: 1 | Canada Vigilance | |
| 332 | Injection Site Reaction | Canada Vigilance: 1 | Canada Vigilance | |
| 333 | Mental impairment | Canada Vigilance: 2 | Canada Vigilance | |
| 334 | Patient restraint | Canada Vigilance: 1 | Canada Vigilance | |
| 335 | Peripheral swelling | Canada Vigilance: 1 | Canada Vigilance | |
| 336 | Product selection error | Canada Vigilance: 1 | Canada Vigilance | |
| 337 | Purpura | Canada Vigilance: 1 | Canada Vigilance | |
| 338 | Skin Ulcer | Canada Vigilance: 1 | Canada Vigilance | |
| 339 | Skin necrosis | Canada Vigilance: 1 | Canada Vigilance | |
| 340 | Therapeutic product effect decreased | Canada Vigilance: 2 | Canada Vigilance | |
| 341 | Therapeutic product effect incomplete | Canada Vigilance: 1 | Canada Vigilance | |
| 342 | Wrong product administered | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.